Patent · US Expired

Compounds and their therapeutic use

US6747057B2 · kind B2 · utility

44Cited by
0References
16Claims
0Family size

Assignees

Inventors

Key dates

Filing dateDec 20, 2002
Grant dateJun 8, 2004
Priority date
Expiry dateDec 20, 2022

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D333/28
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

Compounds of formula I: [wherein:X represents —CH═CH—, —CH═CR—, —CR═CR—, —CO—, —O—, —NH—, —NR—, S—, —SO—, —SO2—, —CH═N—, —CR═N—, —CH═N(O)—, —CR═N(O)— or any other atom or group of atoms capable of forming a S— or 6-membered heterocyclic ring;Y1, Y2 and Y3 independently represent hydrogen or halogen;R1, R2 and R3 are independently represent hydrogen, halogen, hydrocarbyl (—R), hydroxyl (—OH), hydrocarbyloxy (—O—R), mercapto (—SH), hydrocarbylthio (—S—R), hydrocarbylsulfinyl (—SO—R), hydrocarbylsulfonyl (—SO2—R), nitro (—NO2), amino (—NH2), hydrocarbylamino (—NHR), bis(hydrocarbyl)amino (—NR2), hydrocarbylcarbonylamino (—NH—CO—R), cyano (—CN), carbamoyl (—CONH2), hydrocarbylcarbarnoyl (—CONHR), bis(hydrocarbyl)carbamoyl (—CONR2), carboxyl (—CO2H), hydrocarbyloxycarbonyl (—CO2R), formyl (—CHO), hydrocarbylcarbonyl (—COR), hydrocarby…

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.